| Molecular events in the natural history of pancreatic cancer LE Oldfield, AA Connor, S Gallinger Trends in cancer 3 (5), 336-346, 2017 | 75 | 2017 |
| AACR Project GENIE: 100,000 cases and beyond TJ Pugh, JL Bell, JP Bruce, GJ Doherty, M Galvin, MF Green, ... Cancer Discovery 12 (9), 2044-2057, 2022 | 39 | 2022 |
| Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study SR Kim, A Tone, RH Kim, M Cesari, BA Clarke, L Eiriksson, T Hart, ... Gynecologic Oncology 161 (1), 221-227, 2021 | 16 | 2021 |
| Effect of genetics clinical decision support tools on health-care providers’ decision making: a mixed-methods systematic review A Sebastian, JC Carroll, LE Oldfield, C Mighton, S Shickh, E Uleryk, ... Genetics in Medicine 23 (4), 593-602, 2021 | 15 | 2021 |
| Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer SR Kim, A Tone, RH Kim, M Cesari, BA Clarke, L Eiriksson, T Hart, ... Cancer 126 (22), 4886-4894, 2020 | 14 | 2020 |
| An integrative DNA sequencing and methylation panel to assess mismatch repair deficiency LE Oldfield, T Li, A Tone, M Aronson, M Edwards, S Holter, R Quevedo, ... The Journal of Molecular Diagnostics 23 (2), 242-252, 2021 | 13 | 2021 |
| Identifying Core Domains to Assess the “Quality of Death”: A Scoping Review A Bhadelia, LE Oldfield, JL Cruz, R Singh, EA Finkelstein Journal of pain and symptom management 63 (4), e365-e386, 2022 | 10 | 2022 |
| “Game changer”: health professionals’ views on the clinical utility of circulating tumor DNA testing in hereditary cancer syndrome management S Shickh, LE Oldfield, M Clausen, C Mighton, A Sebastian, A Calvo, ... The Oncologist 27 (5), e393-e401, 2022 | 9 | 2022 |
| VHL mosaicism: the added value of multi-tissue analysis LE Oldfield, J Grzybowski, S Grenier, E Chao, GS Downs, KM Farncombe, ... NPJ Genomic Medicine 7 (1), 21, 2022 | 9 | 2022 |
| Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer SR Kim, A Tone, RH Kim, M Cesari, BA Clarke, L Eiriksson, TL Hart, ... Cancer 127 (17), 3082-3091, 2021 | 7 | 2021 |
| Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA D Wong, P Luo, LE Oldfield, H Gong, L Brunga, R Rabinowicz, V Subasri, ... Cancer Discovery 14 (1), 104-119, 2024 | 6 | 2024 |
| Identifying mechanisms of resistance by circulating tumor DNA in EVOLVE, a phase II trial of cediranib plus olaparib for ovarian cancer at time of PARP inhibitor progression S Lheureux, SD Prokopec, LE Oldfield, E Gonzalez-Ochoa, JP Bruce, ... Clinical Cancer Research 29 (18), 3706-3716, 2023 | 5 | 2023 |
| Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers SR Kim, A Tone, R Kim, M Cesari, B Clarke, L Eiriksson, T Hart, ... International Journal of Gynecologic Cancer 30 (12), 2020 | 5 | 2020 |
| Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis D Van Egeren, K Kohli, JL Warner, PL Bedard, G Riely, E Lepisto, ... Scientific Reports 12 (1), 19055, 2022 | 4 | 2022 |
| Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer S El Ghamrasni, R Quevedo, J Hawley, P Mazrooei, Y Hanna, I Cirlan, ... Molecular Cancer Research 20 (1), 102-113, 2022 | 3 | 2022 |
| Comprehensive molecular assessment of mismatch repair deficiency in Lynch-associated ovarian cancers using next-generation sequencing (NGS) panel. RS Kim, LE Oldfield, A Tone, A Pollett, E Van de Laar, S Pedersen, ... Journal of Clinical Oncology 38 (15_suppl), 1523-1523, 2020 | 2 | 2020 |
| Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy KM Farncombe, D Wong, ML Norman, LE Oldfield, JA Sobotka, M Basik, ... The American Journal of Human Genetics 110 (10), 1616-1627, 2023 | 1 | 2023 |
| “I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening Y Bombard, E Adi-Wauran, M Clausen, S Shickh, A Gagliardi, A Denburg, ... | 1 | 2023 |
| “I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening E Adi-Wauran, M Clausen, S Shickh, AR Gagliardi, A Denburg, ... European Journal of Human Genetics 32 (2), 176-181, 2024 | | 2024 |
| Synthesis of Existent Oncology Curricula for Primary Care Providers: A Scoping Review With a Global Equity Lens LE Oldfield, V Jones, B Gill, N Kodous, R Fazelzad, D Rodin, H Sandhu, ... JCO Global Oncology 9, e2200298, 2023 | | 2023 |
